CD274 and neoplasm: In addition, the use of immunotherapy may be effective in the presence of RAS mutations, since the reduction in the number of tumor-infiltrating lymphocytes (TILs), the negative influence on the tumor microenvironment, and the increase in the expression of programmed cell death ligand 1 (PD-L1) are often observed in RAS-mutated tumors.